Search Results - "Labidi-Galy I"

CldU sensitizes BRCA2 reverse-mutated cells to PARP inhibitors.

Authors: Zouggari N Trugenberger C Du Bois V et al.

Source: Frontiers in oncology [Front Oncol] 2025 Nov 19; Vol. 15, pp. 1626301. Date of Electronic Publication: 2025 Nov 19 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

ESGO Statements on Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma.

Authors: Meyer J Labidi-Galy I Ryser M

Source: JAMA [JAMA] 2026 Jul 14; Vol. 336 (2), pp. 166-167.

Publication Type: Journal Article

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE; In Process

Prognostic RNA-splicing archetypes in breast cancer identified by extended pre-training of histopathology foundation models.

Authors: Fournier L Haefliger G Vernhes A et al.

Source: Nature communications [Nat Commun] 2026 Jul 07. Date of Electronic Publication: 2026 Jul 07.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Spatiotemporal organisation of residual disease in mouse and human BRCA1-deficient mammary tumours and breast cancer.

Authors: Túrós D Decollogny M Moyseos A et al.

Source: Nature communications [Nat Commun] 2026 Jun 11. Date of Electronic Publication: 2026 Jun 11.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Rethinking ovarian cancer III: the past decade and future directions.

Authors: Balkwill FR Laumont CM Burdett N et al.

Source: Nature reviews. Cancer [Nat Rev Cancer] 2026 Jun; Vol. 26 (6), pp. 452-471. Date of Electronic Publication: 2026 Apr 13.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124168 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1768 (Electronic) Linking ISSN: 1474175X NLM ISO Abbreviation: Nat Rev Cancer Subsets: MEDLINE

Heterogeneity in Stage IV Ovarian Cancer: Survival Trends in Patients Presenting with Sister Mary Joseph's Nodule.

Authors: Tal O Schötzau A Bizzarri N et al.

Source: Cancers [Cancers (Basel)] 2026 Mar 10; Vol. 18 (6). Date of Electronic Publication: 2026 Mar 10.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

The Experience of Women With Breast or Gynecological Cancer After Participation in an Online Mindfulness-Based Cancer Recovery (e-MBCR) Program: Secondary Outcomes Analysis of a Pilot Mixed Methods Randomized Controlled Trial.

Authors: Gaignard ME Martin D Stanic J et al.

Source: Psycho-oncology [Psychooncology] 2025 Nov; Vol. 34 (11), pp. e70334.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 9214524 Publication Model: Print Cited Medium: Internet ISSN: 1099-1611 (Electronic) Linking ISSN: 10579249 NLM ISO Abbreviation: Psychooncology Subsets: MEDLINE

H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours.

Authors: Dibitetto D Liptay M Vivalda F et al.

Source: Nature communications [Nat Commun] 2024 May 24; Vol. 15 (1), pp. 4430. Date of Electronic Publication: 2024 May 24.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Durable complete response with chemo-immuno-radiotherapy for metastatic cervical cancer progressing under immunotherapy: a case series.

Authors: Westerhoff T Baudoux N Undurraga M et al.

Source: Gynecologic oncology reports [Gynecol Oncol Rep] 2025 Oct 01; Vol. 61, pp. 101967. Date of Electronic Publication: 2025 Oct 01 (Print Publication: 2025).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101652231 Publication Model: eCollection Cited Medium: Print ISSN: 2352-5789 (Print) Linking ISSN: 23525789 NLM ISO Abbreviation: Gynecol Oncol Rep Subsets: PubMed not MEDLINE

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.

Authors: Balmaña J Fasching PA Couch FJ et al.

Corporate Authors: Balmaña J Fasching PA Couch FJ et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Apr; Vol. 204 (2), pp. 237-248. Date of Electronic Publication: 2023 Dec 19.

Publication Type: Clinical Trial, Phase III; Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer.

Authors: Christinat Y Labidi-Galy I Ho L et al.

Source: JCO precision oncology [JCO Precis Oncol] 2025 Jul; Vol. 9, pp. e2400825. Date of Electronic Publication: 2025 Jul 02.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma.

Authors: Le Saux O Ardin M Berthet J et al.

Source: Nature communications [Nat Commun] 2024 Jul 16; Vol. 15 (1), pp. 5932. Date of Electronic Publication: 2024 Jul 16.

Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

The clinical challenges of homologous recombination proficiency in ovarian cancer: from intrinsic resistance to new treatment opportunities.

Authors: Zielli T Labidi-Galy I Del Grande M et al.

Source: Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2023 Jul 28; Vol. 6 (3), pp. 499-516. Date of Electronic Publication: 2023 Jul 28 (Print Publication: 2023).

Publication Type: Journal Article; Review

Journal Info: Publisher: OAE Publishing Inc Country of Publication: United States NLM ID: 101738710 Publication Model: eCollection Cited Medium: Internet ISSN: 2578-532X (Electronic) Linking ISSN: 2578532X NLM ISO Abbreviation: Cancer Drug Resist Subsets: PubMed not MEDLINE

Changes of health-related quality of life 6 months after high-risk oncological upper gastrointestinal and hepatobiliary surgery: a single-centre prospective observational study (ChangeQol Study).

Authors: Maillard J Elia N Ris F et al.

Source: BMJ open [BMJ Open] 2023 Feb 22; Vol. 13 (2), pp. e065902. Date of Electronic Publication: 2023 Feb 22.

Publication Type: Observational Study; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity.

Authors: Lang N Diciola A Labidi-Galy I et al.

Source: BMJ open [BMJ Open] 2023 Jan 05; Vol. 13 (1), pp. e067691. Date of Electronic Publication: 2023 Jan 05.

Publication Type: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

Immunotherapy in Urological, Gynecological and Gastrointestinal Cancers - Current Landscape.

Authors: Borgeaud M Courtes MG Tsantoulis P et al.

Source: Praxis [Praxis (Bern 1994)] 2023; Vol. 112 (3), pp. 149-155.

Publication Type: Journal Article

Journal Info: Publisher: Aerzteverlag medinfo AG Country of Publication: Switzerland NLM ID: 101468093 Publication Model: Print Cited Medium: Print ISSN: 1661-8157 (Print) Linking ISSN: 16618157 NLM ISO Abbreviation: Praxis (Bern 1994) Subsets: MEDLINE

[Intraperitoneal therapy for carcinomatosis in ovarian cancer: proposed treatment algorithm].

Transliterated Title: Traitements intrapéritonéaux de la carcinose ovarienne : proposition d’algorithmes décisionnels.

Authors: Undurraga M Mathevet P Hubner M et al.

Source: Revue medicale suisse [Rev Med Suisse] 2022 May 18; Vol. 18 (782), pp. 990-996.

Publication Type: Journal Article; Review

Journal Info: Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN: 1660-9379 (Print) Linking ISSN: 16609379 NLM ISO Abbreviation: Rev Med Suisse Subsets: MEDLINE

Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer.

Authors: Bordry N Addeo A Jaksic C et al.

Source: IScience [iScience] 2021 Dec 24; Vol. 25 (1), pp. 103699. Date of Electronic Publication: 2021 Dec 24 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.

Authors: Addeo A Shah PK Bordry N et al.

Source: Cancer cell [Cancer Cell] 2021 Aug 09; Vol. 39 (8), pp. 1091-1098.e2. Date of Electronic Publication: 2021 Jun 18.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis.

Authors: Gelmon KA Fasching PA Couch FJ et al.

Corporate Authors: Gelmon KA Fasching PA Couch FJ et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jul; Vol. 152, pp. 68-77. Date of Electronic Publication: 2021 Jun 01.

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE